Meanwhile, NEDD8 knockdown is known to accumulate CRLs substrates through the inactivation of CRLs to inhibit the malignant phenotype, thereby serving as a therapeutic target for ESCC [34]. The gene discussed is NEDD8; the disease is esophageal squamous cell carcinoma.